Pars plana vitrectomy combined with penetrating keratoplasty and transscleral-sutured intraocular lens implantation in complex eyes: a case series.


Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
14 Sep 2020
Historique:
received: 09 06 2020
accepted: 09 09 2020
entrez: 15 9 2020
pubmed: 16 9 2020
medline: 15 5 2021
Statut: epublish

Résumé

The aim of this study was to evaluate the clinical outcomes of pars plana vitrectomy (PPV) combined with penetrating keratoplasty (PKP) and transscleral-sutured intraocular lens (IOL) implantation (IOL-suture) in complex eyes. In this prospective, consecutive interventional case series, patients who underwent PKP combined with PPV and IOL implantation from July 2014 to March 2018 at Yokohama Minami Kyosai Hospital were enrolled. The postoperative best corrected visual acuity (BCVA) (converted to logarithm of the minimal angle of resolution [logMAR] units), intraocular pressure (IOP, mmHg), endothelial cell density (ECD, cells/mm This study included 11 eyes of 11 patients (three females and eight males; mean age, 61.8 ± 13.9 years) with an injury (n = 6) or bullous keratopathy (n = 5). The BCVA significantly improved from 1.50 ± 0.66 logMAR preoperatively to 0.78 ± 0.59 logMAR (p < 0.001) postoperatively. The baseline ECD significantly decreased from 2396 ± 238 cells/mm The combination of PKP, PPV, and IOL-suture implantation could be a safe and effective approach for eyes requiring anterior segment surgery; however, these eyes are associated with a higher incidence of glaucoma surgery.

Sections du résumé

BACKGROUND BACKGROUND
The aim of this study was to evaluate the clinical outcomes of pars plana vitrectomy (PPV) combined with penetrating keratoplasty (PKP) and transscleral-sutured intraocular lens (IOL) implantation (IOL-suture) in complex eyes.
METHODS METHODS
In this prospective, consecutive interventional case series, patients who underwent PKP combined with PPV and IOL implantation from July 2014 to March 2018 at Yokohama Minami Kyosai Hospital were enrolled. The postoperative best corrected visual acuity (BCVA) (converted to logarithm of the minimal angle of resolution [logMAR] units), intraocular pressure (IOP, mmHg), endothelial cell density (ECD, cells/mm
RESULTS RESULTS
This study included 11 eyes of 11 patients (three females and eight males; mean age, 61.8 ± 13.9 years) with an injury (n = 6) or bullous keratopathy (n = 5). The BCVA significantly improved from 1.50 ± 0.66 logMAR preoperatively to 0.78 ± 0.59 logMAR (p < 0.001) postoperatively. The baseline ECD significantly decreased from 2396 ± 238 cells/mm
CONCLUSION CONCLUSIONS
The combination of PKP, PPV, and IOL-suture implantation could be a safe and effective approach for eyes requiring anterior segment surgery; however, these eyes are associated with a higher incidence of glaucoma surgery.

Identifiants

pubmed: 32928189
doi: 10.1186/s12886-020-01639-y
pii: 10.1186/s12886-020-01639-y
pmc: PMC7491070
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

369

Références

Ophthalmology. 2017 Aug;124(8):1136-1142
pubmed: 28457613
Cornea. 2003 Apr;22(3):194-7
pubmed: 12658081
Ophthalmology. 2003 Jul;110(7):1396-402
pubmed: 12867398
Korean J Ophthalmol. 2012 Dec;26(6):432-7
pubmed: 23204798
Ophthalmology. 2001 Nov;108(11):1978-85
pubmed: 11713065
J Glaucoma. 2010 Feb;19(2):124-31
pubmed: 19528824
Am J Ophthalmol. 2008 Feb;145(2):203-209
pubmed: 18222190
Graefes Arch Clin Exp Ophthalmol. 2009 Jan;247(1):137-42
pubmed: 18766368
Am J Ophthalmol. 2005 Dec;140(6):1112-22
pubmed: 16376660
Cornea. 2004 Aug;23(6):554-9
pubmed: 15256992
Eur J Ophthalmol. 2010 Sep-Oct;20(5):885-91
pubmed: 20491042
J Ophthalmol. 2014;2014:794039
pubmed: 25105021
Int J Ophthalmol. 2013 Apr 18;6(2):183-6
pubmed: 23638421
Cornea. 2016 Sep;35(9):1261-5
pubmed: 27429080
Cornea. 2003 Jul;22(5):429-34
pubmed: 12827048
PLoS One. 2012;7(5):e37867
pubmed: 22629464
Refract Corneal Surg. 1989 Jul-Aug;5(4):258-61
pubmed: 2488816
Ophthalmology. 2014 May;121(5):979-87
pubmed: 24491643
Ophthalmology. 2011 Jan;118(1):209-18
pubmed: 21199711
Int Ophthalmol Clin. 2000 Winter;40(1):27-43
pubmed: 10713912
Int Ophthalmol. 2016 Aug;36(4):541-6
pubmed: 26646776
Am J Ophthalmol. 2018 Apr;188:91-98
pubmed: 29410297
Graefes Arch Clin Exp Ophthalmol. 2020 Jul 20;:
pubmed: 32685994
J Cataract Refract Surg. 1992 Mar;18(2):201-2
pubmed: 1564664
Cornea. 2007 Oct;26(9):1060-6
pubmed: 17893534
Am J Ophthalmol. 2000 Apr;129(4):468-71
pubmed: 10764855
Curr Eye Res. 2017 Mar;42(3):436-442
pubmed: 27348314
Cornea. 2018 Nov;37 Suppl 1:S78-S85
pubmed: 30216334
Am J Ophthalmol. 2004 Aug;138(2):200-5
pubmed: 15289127
J Ophthalmol. 2018 Aug 13;2018:9034964
pubmed: 30186628
Curr Opin Ophthalmol. 2014 Jul;25(4):300-5
pubmed: 24865170
Br J Ophthalmol. 2020 May;104(5):712-717
pubmed: 31434648

Auteurs

Takahiko Hayashi (T)

Department of Ophthalmology, Yokohama Minami Kyosai Hospital, 1-21-1, Mutsuura Higashi, Yokohama, Kanagawa, 236-0037, Japan. takamed@gmail.com.
Department of Ophthalmology, University of Cologne, Cologne, Germany. takamed@gmail.com.
Department of Ophthalmology, Jichi Medical University, Tochigi, Shimotsuke, Japan. takamed@gmail.com.
Department of Ophthalmology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan. takamed@gmail.com.
Department of Technology and Design Thinking for Medicine (DT2M), Hiroshima University, Hiroshima, Japan. takamed@gmail.com.

Ida Yasutsugu (I)

Department of Ophthalmology, Yokohama Minami Kyosai Hospital, 1-21-1, Mutsuura Higashi, Yokohama, Kanagawa, 236-0037, Japan.
Department of Ophthalmology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan.

Toshiki Shimizu (T)

Department of Ophthalmology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan.

Tsubasa Kuroki (T)

Department of Ophthalmology, Yokohama Minami Kyosai Hospital, 1-21-1, Mutsuura Higashi, Yokohama, Kanagawa, 236-0037, Japan.

Yuji Kobashigawa (Y)

Yokosuka Chuo Eye Clinic, Yokohama, Kanagawa, Japan.

Yasuhito Iijima (Y)

Sofukai Oppama Ekimae Eye Clinic, Yokohama, Kanagawa, Japan.

Kentaro Yuda (K)

Department of Ophthalmology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan.
Angiogenesis Laboratory, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, USA.
Kikuna Yuda Eye Clinic, Yokohama, Kanagawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH